EVIDENCE Q&A
Does EGF actually work — or has it already died in the bottle before you open it?
Published 2026-04-17
What I think
In one gold-standard trial, topical EGF reduced melasma severity 5.6 times more than placebo. That's one of the largest effect sizes I've seen for any topical skincare ingredient. The problem: the EGF in your serum may already be dead by the time you open the bottle.
Growth factors are notoriously unstable in standard cosmetic packaging. The clinical trials used controlled formulations at specific concentrations. Most consumer EGF products don't disclose their concentration, and there's no easy way to tell if the active ingredient has degraded. EGF is a promising ingredient with a packaging problem.
What the research suggests
A 2014 randomized, double-blind, placebo-controlled, split-face trial in the International Journal of Dermatology tested topical EGF on acne lesions. The EGF side showed a 34% greater improvement in pore refinement and 50% greater reduction in redness compared to placebo. Hydration improved by 10%, and oil balance improved by 20%. The study used 48 subjects over 8 weeks.
For pigmentation, the results were more dramatic. A 2018 randomized, double-blind, placebo-controlled, split-face trial in the Journal of Drugs in Dermatology found that topical EGF reduced melasma severity by 5.6 times more than placebo over 12 weeks. That's a large effect size, but it's a single study, and the population was specifically melasma patients.
The catch: both studies used clinical-grade EGF formulations at specific concentrations, applied under controlled conditions. Most consumer EGF products don't disclose their EGF concentration, and growth factors are notoriously unstable in standard cosmetic packaging. Whether the EGF in your serum is still active by the time you apply it is an open question.
What I'd actually pay attention to
If the product doesn't disclose its EGF concentration and isn't in airless, opaque packaging, you're probably paying for a label, not an active ingredient. Look for clinical-grade formulations with transparent concentration data and stability-tested packaging.
EGF is a tier above most peptides in terms of evidence, but a tier below retinoids in terms of real-world reliability. The ingredient works. Whether the product on the shelf still contains it is the question nobody is asking.
This is educational guidance based on published research, not individualized medical advice. If you are dealing with severe irritation, melasma, rosacea, eczema, pregnancy-related skincare questions, or a prescription reaction, talk to a clinician.
Sources
- Kim 2014 — Topical EGF improved acne lesions in a randomized, double-blind, placebo-controlled, split-face trial of 48 subjects; 34% greater pore refinement vs. placebo over 8 weeks. International Journal of Dermatology. PubMed
- Lyons 2018 — Topical EGF reduced melasma severity 5.6x more than placebo in a randomized, double-blind, placebo-controlled, split-face trial over 12 weeks. Journal of Drugs in Dermatology. PubMed
Other questions
- Is your OTC retinol even strong enough to cause purging?
- Is your ceramide cream missing the two ingredients that make ceramides actually work?
- Is niacinamide worth the hype — or are you paying for a B vitamin?
- How close is OTC retinol to prescription tretinoin — and is the 9% gap worth the side effects?
- Did four ingredients really match hydroquinone for dark spots in head-to-head trials?
Get the next breakdown first
Next week: four ingredients matched hydroquinone in head-to-head trials between 2022 and 2025. The landscape for dark spots changed almost entirely in three years. I am ranking the alternatives.
One comparison per week. Unsubscribe anytime.